Novo Nordisk CEO Lars Fruergaard Jørgensen weighs in the company's latest obesity drug offering, including its new oral ...

Presenter: Motti Farbstein, Chief Executive & Chief Financial Officer ...

Wegovy obesity drug sales more than double but set to slow - Sales of Wegovy, a prescription weight loss injection, surged to ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...